Acute Myocardial Infarction Research
Acute Myocardial Infarction Research is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 45k research works in it since 1950. 17.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the management, diagnosis, and treatment of acute myocardial infarction (heart attacks), including topics such as ST-segment elevation, troponin assays, thrombolytic therapy, primary angioplasty, and risk assessment. It also includes guidelines and recommendations for the management of acute coronary syndromes and cardiovascular disease.
- Myocardial Infarction
- Acute Coronary Syndromes
- ST-Segment Elevation
- Primary Angioplasty
- Troponin Assays
- Cardiovascular Disease
- Guidelines
- Thrombolytic Therapy
- Risk Score
- Reperfusion Therapy
- Research works
- 45k fractional, since 1950
- In the world top 10%
- 8k per year above
- Top-10% rate
- 17.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +21% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Acute Myocardial Infarction Research research?
By volume, the United States and China publish the most (1.6k and 836 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.6k works
- 2 China 836 works
- 3 United Kingdom 351 works
- 4 Italy 313 works
- 5 India 292 works
- 6 Japan 290 works
- 7 Germany 268 works
- 8 Pakistan 259 works
- 9 Spain 255 works
- 10 Australia 227 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Acute Myocardial Infarction Research research?
By volume in 2022–2025, National Institute of Cardiovascular Diseases publishes the most Acute Myocardial Infarction Research research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Capital Medical University.
By volume, 2022–2025
- 1 National Institute of Cardiovascular DiseasesPakistan 48 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 39 works
- 3 Capital Medical UniversityChina 29 works
- 4 University of North Carolina at Chapel HillUnited States 25 works
- 5 Harvard UniversityUnited States 23 works
- 6 Icahn School of Medicine at Mount SinaiUnited States 23 works
- 7 Brigham and Women's HospitalUnited States 21 works
- 8 Beijing Anzhen HospitalChina 21 works
- 9 Sağlık Bilimleri ÜniversitesiTürkiye 20 works
- 10 Aarhus University HospitalDenmark 17 works
Who are the leading researchers in Acute Myocardial Infarction Research?
The most-cited researchers publishing on Acute Myocardial Infarction Research include William B. Kannel, Valentı́n Fuster and Sidney C. Smith.
- 1 William B. Kannel United States 5.7k citations
- 2 Valentı́n Fuster United States 5.4k citations
- 3 Sidney C. Smith Australia 5.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Acute Myocardial Infarction Research research done?
The largest centres of Acute Myocardial Infarction Research research in 2022–2025 are Beijing (China), London (United Kingdom), Seoul (South Korea) and Karachi (Pakistan). Among places with at least 20 works in it, it is an unusually large share of all research in Peshawar and Karachi.
Largest cities, 2022–2025
Where it is the local speciality
- PeshawarPK · 47.6 works10×
- KarachiPK · 92.1 works9.8×
Location quotient: how much more of its research is in Acute Myocardial Infarction Research than the world average.
Where is the best place to study Acute Myocardial Infarction Research?
Among universities, judged by research, Icahn School of Medicine at Mount Sinai, Chinese Academy of Medical Sciences & Peking Union Medical College and Samara State Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Icahn School of Medicine at Mount SinaiUnited States | 56.4 | 21.5% | 6.3× | 23 | +79.2% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 55.6 | 15.2% | 5.5× | 39 | +114.3% |
| 3 | Samara State Medical UniversityRussia | 54.9 | 21.8% | 24.7× | 13 | — |
| 4 | Karolinska InstitutetSweden | 54.0 | 21.6% | 4.9× | 16 | +54.5% |
| 5 | Keele UniversityUnited Kingdom | 52.9 | 13.5% | 16.6× | 12 | — |
| 6 | Dow University of Health SciencesPakistan | 47.9 | 10.5% | 10.8× | 10 | — |
| 7 | Harvard UniversityUnited States | 47.7 | 25.5% | 2.5× | 23 | -1.4% |
| 8 | Wake Forest UniversityUnited States | 47.4 | 24.2% | 7.1× | 13 | -12.4% |
| 9 | Capital Medical UniversityChina | 47.2 | 12.0% | 6.9× | 29 | +16.4% |
| 10 | Medical University of ViennaAustria | 47.2 | 28.6% | 4.7× | 11 | -21.1% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Acute Myocardial Infarction Research research growing?
Output in 2018–2022 was 21% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Acute Myocardial Infarction Research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.